Please check your internet connection and try again.
# Chloroxazone
## Overview
- **Classification**: Centrally acting skeletal muscle relaxant
- **Mechanism**: Acts at the spinal cord and subcortical areas of the brain to inhibit polysynaptic reflex arcs involved in muscle spasm, leading to muscle relaxation.
## Primary Indications
1. **Muscle Spasm** - Relief of discomfort associated with acute, painful musculoskeletal conditions.
## Adult Dosing
### Standard Dosing
**Acute Painful Musculoskeletal Conditions**
- **Dose**: **250 mg** to **750 mg**
- **Frequency**: Three to four times daily (TID/QID)
- **Route**: Oral
- **Duration**: Short-term, as needed for acute spasm
- **Maximum Dose**: **3000 mg** per day
### Dose Adjustments
- **Renal Impairment**: No specific dose adjustments provided; use with caution.
- **Hepatic Impairment**: **Contraindicated** in patients with known hepatic impairment. Use with extreme caution and reduce dose if mild impairment, monitoring LFTs closely.
- **Elderly Patients**: Start with lower doses (e.g., **250 mg TID**) due to increased sensitivity to CNS effects and potential for decreased metabolism. Monitor closely for sedation and falls.
## Pediatric Dosing
**Note**: Chloroxazone is generally **not recommended** for children under **12 years of age** due to lack of established safety and efficacy data.
### Neonates (0-28 days)
- **Dose**: **Not recommended**.
- **Special Notes**: Safety and efficacy have not been established. Avoid use.
### Infants (1-12 months)
- **Dose**: **Not recommended**.
- **Special Notes**: Safety and efficacy have not been established. Avoid use.
### Children (1-12 years)
- **Dose**: **Not recommended**.
- **Special Notes**: Safety and efficacy have not been established. Avoid use.
### Adolescents (13-18 years)
- **Dose**: Limited data. Some sources suggest **125-250 mg TID-QID**; however, adult dosing is often approached with caution.
- **Maximum**: Refer to adult maximum dose (**3000 mg/day**) if used, but generally start lower.
- **Special Notes**: Closely monitor for sedation and other adverse effects. Consider alternative agents with better-established pediatric data.
## Safety Information
### Contraindications
- **Absolute**: Known hypersensitivity to chloroxazone or any component.
- **Absolute**: Pre-existing hepatic impairment or liver disease.
### Common Adverse Effects
- **Very Common (>10%)**: Drowsiness, dizziness, lightheadedness.
- **Common (1-10%)**: Nausea, vomiting, GI upset, heartburn.
- **Serious but Rare**: Hepatotoxicity (jaundice, liver enzyme elevation), angioedema, GI bleeding, hypersensitivity reactions.
### Key Drug Interactions
- **CNS Depressants (Alcohol, Benzodiazepines, Opioids)**: Increased risk of additive CNS depression (sedation, respiratory depression). Avoid concomitant use or reduce doses.
- **Hepatotoxic Agents**: Increased risk of liver injury when co-administered. Monitor LFTs closely.
- **CYP2E1 Inducers/Inhibitors**: Chloroxazone is metabolized by CYP2E1; interactions possible, but clinical significance often low for short-term use.
## Monitoring & Follow-up
- **Before Treatment**: Obtain baseline liver function tests (LFTs) if prolonged use or risk factors for hepatic impairment exist.
- **During Treatment**: Monitor for signs of CNS depression (sedation, dizziness). Observe for signs of hepatic dysfunction (jaundice, dark urine, abdominal pain).
- **Clinical Signs**: Watch for persistent GI upset, unexplained fatigue, or allergic reactions.
## Clinical Pearls
- 💡 **Tip 1**: Take with food or milk to minimize gastrointestinal upset.
- 💡 **Tip 2**: Advise patients about potential drowsiness and dizziness; avoid driving or operating heavy machinery until effects are known.
- 💡 **Tip 3**: Counsel patients to avoid alcohol and other CNS depressants due to additive sedative effects.
- 💡 **Tip 4**: Discontinue chloroxazone if signs of liver dysfunction occur and consult a physician immediately.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.